To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who h…

Low RiskPapillary Thyroid CancerRadiofrequency Ablation

~Estimated

~$10 – $750

M.D. Anderson Cancer CenterNCT07140757

Phase 1

An Open-label, Phase 1b Study of R289, an IRAK1/4 Inhibitor, in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS) Who Are Relapsed/Refractory/Resistant to Prior Therapies

Phase 1b Study of R289 in Patients with Lower-risk Myelodysplastic Syndromes (LR MDS)

Low Risk Myelodysplastic Syndromes

~Estimated

~$10 – $8,750

Rigel PharmaceuticalsNCT05308264

Observational

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

This clinical trial tests next generation sequencing (NGS) for the detection of precursor features of pre-myeloid cancers and bone marrow failure syndromes. NG…

Myeloid MalignancyInherited Bone Marrow Failure SyndromeClonal Expansion+10 more

~Estimated

~$10 – $6,250

Mayo ClinicNCT02958462